Edward Rockenstein
15Patents
7h-index
15Co-inventors
63Inventor score
Filing activity: Oct 6, 1998 → Nov 3, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8092801B2 | Prevention and treatment of synucleinopathic and amyloidogenic disease | Chemistry; Metallurgy | 34 | Active |
| US7919088B2 | Treatment and delay of onset of synucleinopathic and amyloidogenic disease | Chemistry; Metallurgy | 34 | Active |
| US6107477A | Non-optimal Kozaks sequences | Chemistry; Metallurgy | 17 | Expired |
| US8147833B2 | Prevention and treatment of synucleinopathic and amyloidogenic disease | Chemistry; Metallurgy | 13 | Active |
| US8506959B2 | Prevention and treatment of synucleinopathic and amyloidogenic disease | Human Necessities | 9 | Active |
| US7393994B2 | Transgenic mouse model for neurodegenerative diseases | Chemistry; Metallurgy | 9 | Expired |
| US8450481B2 | Compounds for inhibiting protein aggregation, and methods for making and using them | Human Necessities | 8 | Active |
| US8846682B2 | Compound suitable for the treatment of synucleopathies | Chemistry; Metallurgy | 6 | Active |
| US9034337B2 | Treatment and delay of outset of synucleinopathic and amyloidogenic disease | Chemistry; Metallurgy | 5 | Active |
| US7226746B1 | Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease | Physics | 1 | Expired |
| US7459601B2 | Human α synuclein expressing transgenic mice | Chemistry; Metallurgy | 0 | Expired |
| US8946165B2 | Compounds for reversing and inhibiting protein aggregation, and methods for making and using them | Human Necessities | 0 | Active |
| US7795495B2 | Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them | Chemistry; Metallurgy | 0 | Active |
| US10947302B2 | Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them | Physics | 0 | Active |
| US7276643B2 | Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.